Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2018 PRIZE WINNERS

2018 Prize Winners

News

May 22. 2018
PRESS RELEASE: SEVEN NEW YORK CITY-AREA SCIENTISTS WIN PERSHING SQUARE SOHN PRIZE FOR YOUNG INVESTIGATORS IN CANCER RESEARCH

The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2018 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to promising early career, New York City-area cancer research scientists. Recipients receive $200,000 in funding per year for up to three years, for a total of $600,000, to support bold research at a stage when traditional funding is often lacking. The awards will be presented on May 23, 2018.

READ MORE

Events

April 23, 2018 
23RD ANNUAL SOHN INVESTMENT CONFERENCE

Since 1995, the world-renowned Sohn Investment Conference, held annually in New York, has been the premier investment event, bringing the world’s savviest investors together to share fresh insights and money-making ideas to benefit The Sohn Conference Foundation’s work to end childhood cancer. The 23rd Annual Sohn Investment Conference was held on Monday, May 23rd at Daivd Geffen Hall in Lincoln Center.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation